
    
      This study consists of 2 parts: a longitudinal study enrolling 3,000 health care
      professionals at the Vienna General Hospital testing their antibody status 6 times over a
      period of 12 months (Cohort A), and a serial cross-sectional study of 3,000 patients (i.e., a
      total of 9,000 patients) admitted to the Vienna General Hospital for non-COVID-19-related
      symptoms at 3 different time points during this pandemic (Cohort B).
    
  